RH
Ryman Healthcare Limited
RHCGF · OTC
$1.12 +0.75% (+$0.01)
1M -25.00%
Market Cap $1.97B
P/E Ratio -
Div. Yield -
ROE 4.12%
Bulios Fair Price
$0.96
14.3% downside
Current Price
$1.12
Undervalued Fair Value Overvalued
According to Bulios Fair Price, RHCGF is currently overvalued relative to its market price. How does it work?
Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Piotroski F-Score Moderate
4/9Valuation
60 /100
Fair P/FCF 7.16x
P/B 0.48x
EV/EBITDA 142.48x
Growth
60 /100
Stable FCF growth 7.97%
Book val. growth 4.06%
Rev. growth 12.92%
Profitability
30 /100
Weak FCF margin 34.11%
Op. margin 2.22%
Gross margin 2.22%
Quality
1 /100
Poor Asset turnover 0.07x
ROA 1.40%
ROIC 0.14%
Debt
29 /100
High Net debt/EBITDA 63.82x
Int. coverage -0.15x
Debt/Equity 0.39x
Stability
40 /100
Moderate Profitable years 0
EPS volatility 5,154.91%
Beta 0.34x
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Ask StockBot about RHCGF
Online
Sector
Healthcare
Industry
Medical - Care Facilities
CEO
Naomi James
Employees
7,700
Headquarters
Christchurch
Upcoming events
20 NOV
Earnings
Upcoming earnings report